Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2181301
Max Phase: Preclinical
Molecular Formula: C51H78N14O11
Molecular Weight: 1063.27
Molecule Type: Protein
Associated Items:
ID: ALA2181301
Max Phase: Preclinical
Molecular Formula: C51H78N14O11
Molecular Weight: 1063.27
Molecule Type: Protein
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
Standard InChI: InChI=1S/C51H78N14O11/c1-28(2)22-36(47(73)59-34(18-12-20-57-51(55)56)45(71)60-35(42(54)68)24-31-14-8-6-9-15-31)63-49(75)40-19-13-21-65(40)50(76)39(23-29(3)4)64-48(74)38(26-41(53)67)61-43(69)30(5)58-46(72)37(62-44(70)33(52)27-66)25-32-16-10-7-11-17-32/h6-11,14-17,28-30,33-40,66H,12-13,18-27,52H2,1-5H3,(H2,53,67)(H2,54,68)(H,58,72)(H,59,73)(H,60,71)(H,61,69)(H,62,70)(H,63,75)(H,64,74)(H4,55,56,57)/t30-,33-,34-,35-,36-,37-,38-,39-,40-/m0/s1
Standard InChI Key: XSQPTZBZDXKPKC-KYHHBYFOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1063.27 | Molecular Weight (Monoisotopic): 1062.5974 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Nichols R, Bass C, Demers L, Larsen B, Li E, Blewett N, Converso-Baran K, Russell MW, Westfall MV.. (2012) Structure-activity studies of RFamide-related peptide-1 identify a functional receptor antagonist and novel cardiac myocyte signaling pathway involved in contractile performance., 55 (17): [PMID:22909119] [10.1021/jm300760m] |
Source(1):